Vaccines are here to stay and many companies will have a good balance sheet in coming years. Moderna is a buy and I am DCAing from 186 down to every monthly dip.
MRNA will recover above 200 within 2022
Catatan
MRNA is simply bottoming, should be 200+ in a few months.
Catatan
Still waiting and expecting a decent rebound above 200.
Catatan
Good earnings, and a solid cash flow in MRNA...Ignoring the FUD.
Still MRNA is in business. Looking forward to 200+ finally.
Catatan
Pure sideways market - it is here to stay. I loaded more MRNA around 172.x. Can it deliver 225 this year? That should what we ask, instead SIG *Stay-in the Game*
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.